You are here

drug pricing

Accelerated FDA approval and pricey drugs make a rotten combo, doctors argue

Accelerated FDA approval and pricey drugs make a rotten combo, doctors argue

Fierce Pharma

Flag link:

Nearly every $100,000 drug approved in the last three years was for a rare disease

Nearly every $100,000 drug approved in the last three years was for a rare disease

Medical Marketing and Media

Flag link:

Trump's Quiet on Drug Pricing, But His FDA Isn't

Trump's Quiet on Drug Pricing, But His FDA Isn't

Bloomberg

Flag link:

Trump Budget Contains Little on Drug Prices Despite Tough Talk

Trump Budget Contains Little on Drug Prices Despite Tough Talk

Bloomberg

Flag link:

Nevada bill could force Sanofi, Novo and Lilly to reveal their insulin pricing secrets

Nevada bill could force Sanofi, Novo and Lilly to reveal their insulin pricing secrets

Fierce Pharma

Flag link:

Clinical trial participants should have a say in new drug pricing

Clinical trial participants should have a say in new drug pricing

Stat

Flag link:

Sanofi rejects US Army request for ‘fair’ pricing for a Zika vaccine

Sanofi rejects US Army request for ‘fair’ pricing for a Zika vaccine

Stat

Flag link:

FDA commissioner Scott Gottlieb sets some goals: Find ways to lower drug prices, use new tech to speed development

FDA commissioner Scott Gottlieb sets some goals: Find ways to lower drug prices, use new tech to speed development

Endpoints

drug development

Flag link:

PhRMA Pitches Pricing Ideas To Price

PhRMA Pitches Pricing Ideas To Price

BioCentury

Flag link:

WHO Officials Offer Opposition to Value-Based Drug Pricing

WHO Officials Offer Opposition to Value-Based Drug Pricing

RAPS.org

value-based drug pricing

Flag link:

How Big Pharma Might Be Cut Down To Size

How Big Pharma Might Be Cut Down To Size

Forbes

Marathon Pharma

Flag link:

New study points to a double-digit hike in branded drug prices, spotlighting a growing national debate

New study points to a double-digit hike in branded drug prices, spotlighting a growing national debate

Endpoints

Flag link:

PTC to launch DMD drug with still high price tag

PTC to launch DMD drug with still high price tag

BioPharma Dive

PTC Therapeutics

Duchenne Muscular Dystrophy

Flag link:

Sanofi joins pharma pricing pledge ranks

Sanofi joins pharma pricing pledge ranks

BioPharma Dive

Olivier Brandicourt

Flag link:

The First ALS Drug In 22 Years Is Approved -- And It Costs 4 Times What It Does In Japan

The First ALS Drug In 22 Years Is Approved -- And It Costs 4 Times What It Does In Japan

Forbes

Flag link:

Pricing furor aside, drug spending growth slowed last year—but still hit $323B

Pricing furor aside, drug spending growth slowed last year—but still hit $323B

Fierce Pharma

Flag link:

Look out, Glaxo: Advair is Express Scripts' next big cost-savings target

Look out, Glaxo: Advair is Express Scripts' next big cost-savings target

Fierce Pharma

Express Scripts

Flag link:

BioMarin CEO says 'the system will have to determine' the worth of its new $702,000 drug

BioMarin CEO says 'the system will have to determine' the worth of its new $702,000 drug

CNBC

Flag link:

These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016

These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016

Motley Fool

Flag link:

Neurocrine Biosciences’ new drug may cost patients more than $10,000 a month, twice as much as expected

Neurocrine Biosciences’ new drug may cost patients more than $10,000 a month, twice as much as expected

Marketwatch

tardive dyskinesia

Flag link: